期刊文献+

恶性黑色素瘤细胞凋亡特点的研究进展 被引量:5

The characteristics of invasion and metastasis in malignant melanoma and apoptosis
下载PDF
导出
摘要 对外界广泛刺激原的反应失去诱导细胞凋亡的能力,使恶性黑色素瘤在进展和转移方面获得选择的优势及对常规治疗方法的不敏感性。基因组的突变(p53)、G蛋白和蛋白激酶(Ras等)转录、转录后水平及转录因子效应基因(NF-κB、c-jun、stat3、ATF2)的变化、抗凋亡基因(Bcl-2、Bcl-XL、surviving、ML-IAP等)的表达上调,均影响TNF、Fas、TRAIL受体等诱导细胞凋亡的途径,在恶性黑色素瘤获得抗凋亡能力方面起重要作用。参与凋亡通路信号传导的分子蛋白其复杂的变异性,说明恶性黑色素瘤细胞有许多种调节凋亡及产生凋亡不足的可能性。进一步理解这些分子信号蛋白的相互作用机制及参与调控凋亡的途径,认识他们在黑色素瘤细胞凋亡失调过程中的作用,识别黑色素瘤逃避凋亡刺激的不同路线,或许能为黑色素瘤提供一个新的预防、治疗方法。 Impaired ability to undergo apoptosis in response to a wide range of external stimuli acquires melanomas a selective advantage for progression and metastasis as well as their notorious resistance to therapy. Changes at genomic, transcriptional and post-translational levels of G-proteins and protein kinases (Ras) , their transcription factor effectors (c-jun, ATF2, stat3 and NF-kB) and upregulator of antiapoptosis gene ( Bcl-2, Bcl-XL, survivin, ML-IAP) affects apoptosis-induced of TNF, Fas and TRAIL receptors, which play important roles in acquiring melanoma' s resistance to apoptosis. The complexity of the molecular variants involved in signal transduction along apoptotic pathways suggests that the cell may have a variety of possibilities for regulating apoptosis and generating apoptosis deficiency.
出处 《医学研究生学报》 CAS 2005年第9期849-852,共4页 Journal of Medical Postgraduates
关键词 恶性黑色素瘤 侵袭 转移 凋亡 Malignant melanoma Invasion Metastasis Apoptosis
  • 相关文献

参考文献19

  • 1Slominski A, Wortsman J, Carlson AJ, et al. Malignant melanoma [ J ]. Arch Pathol Lab Med, 2001,125 ( 10 ): 1295-306.
  • 2Bullani RR, Wehrli P, Viard-Leveugle I, et al. Frequent downregulation of Fas ( CD95 ) expression and function in melanoma [J]. Melanoma Res, 2002,12(3) :263-270.
  • 3Reichmann E. The biological role of the Fas/FasL system during tumor formation and progression [ J ]. Semin Cancer Biol, 2002,12(4) :309-315.
  • 4Zheng Y, Ouaaz F, Bruzzo P,et al. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death [ J ]. J Immunol,2001,166 ( 8 ) :4949-4957.
  • 5Eberle J, Fecker LF, Hossini AM, et al. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants[ J]. Oncogene ,2003,22( 57 ) :9131-9134.
  • 6Shukuwa T, Katayama I, Koji T. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas[ J]. Mod Pathol,2002,15 (4) :387-396.
  • 7Song JH, Song DK, Herlyn M,et al. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1 beta-converting enzyme-like inhibitory proteins to restore tumor necrosis facto r-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells [ J ]. Clin Cancer Res, 2003,9 ( 11 ): 4255-4266.
  • 8Zhang XY, Zhang XD, Borrow JM,et al. Translational control of tumor necrosis factor-related apoptosis-inducing ligand death receptor expression in melanoma cells[ J]. J Biol Chem,2004,279( 11 ): 10606-10614.
  • 9Tollefson AE, Toth K, Doronin K ,et al. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins [ J ]. J Virol, 2001,75 ( 19 ): 8875-8887.
  • 10Yoshizumi M, Fujita Y, Izawa Y,et al. Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells [ J ]. Exp Cell Res,2004,292( 1 ): 1-10.

同被引文献83

  • 1姜会庆,胡心宝,汪涌,汪军,解伟光,陈一飞.头部恶性黑色素瘤扩大切除及自体皮移植[J].医学研究生学报,2004,17(11):1049-1049. 被引量:1
  • 2张诗武,孙保存,赵秀兰,刘岩雪,郝希山.恶性黑色素瘤浸润转移相关分子机制研究[J].天津医药,2005,33(2):65-67. 被引量:3
  • 3邱大胜,孔祥泉,石健.多发性原发于椎管的脊膜黑色素细胞瘤一例[J].中华放射学杂志,2005,39(4):447-448. 被引量:5
  • 4雷静,韩丹,王克超.恶性黑色素瘤的CT诊断[J].临床放射学杂志,2006,25(8):727-730. 被引量:13
  • 5伍岳,王文军.ras与肿瘤[J].医学临床研究,2006,23(12):2014-2017. 被引量:1
  • 6Gwosdz C, Scheckenbach K, Lieven O, et al. Comprehensive ananlysis of the p53 status in mucosal and cutaneous mela- nomas[J]. Tnt J Cancer,2006,118(3):577 -582.
  • 7Bunz F, Hwang PM, Torrance C, et al. Disruption of p53 in human cancer alters the responses to theraputie agents[J]. J Clin Invest, 1999,104 ( 3 ) : 263 - 269.
  • 8Satyamoorthy K, Chehab NH, Waterman M J, et al. Aberrant regulation and function of wild - type p53 in radioresistant melanoma cells [ J ]. Cell Growth Differ, 2000,11 ( 9 ) : 467 - 474.
  • 9Tang L, Tron VA, Reed JC, et al. Expression of apoptosisregulations in cutaneous malignant melanoma [ J ]. Clin Cancer Res, 1998,4 ( 8 ) : 1865 - 1871.
  • 10Bullani RR, Wehrli P, Viard - Leveugle I, et al. Frequent down - regulation of Fas( CD95 ) expression and function in melanoma [ J ]. Melanoma Res ,2002,12 ( 3 ) :263 - 270.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部